Chronic Myeloid Leukemia Face-Off: Memorial Sloan Kettering vs Dana-Farber - Episode 6

Ponatinib after TKI Failure in Chronic Myeloid Leukemia

Dr DeAngelo shares data on the use of ponatinib for CML treatment after failure of second-generation TKIs.